Back to Search Start Over

A Randomized Trial Comparing Antibiotics with Appendectomy for Appendicitis

Authors :
Nathan I. Shapiro
Darin J. Saltzman
Patricia Ayoung-Chee
Brett A. Faine
Lisa Ferrigno
Amy H. Kaji
Bonnie J. Bizzell
Heather L. Evans
Amber K. Sabbatini
Hasan B. Alam
Danielle C. Lavallee
Joe H Patton
David R. Flum
Patrick J. Heagerty
Damien W Carter
Julianna T Yu
Callie M Thompson
Pauline K. Park
Karen McGrane
Larry Kessler
Joseph Cuschieri
Careen S Foster
Vance Sohn
Giana H. Davidson
Dionne A. Skeete
Stephen R. Odom
Daniel A. DeUgarte
Sarah E. Monsell
Steven M. Steinberg
Thea P Price
Katherine A Mandell
Gregory J. Moran
Jeffrey L. Johnson
Matthew E. Kutcher
Shaina M Schaetzel
Bruce Chung
William K. Chiang
David A. Talan
Abigail Wiebusch
Erin Fannon
Mike K Liang
Coda Collaborative
Sunday Clark
Amy Rushing
Katherine Fischkoff
Wesley H. Self
Anusha Krishnadasan
Sabrina E. Sanchez
Lillian S Kao
Robert J. Winchell
F. Thurston Drake
Bryan A. Comstock
Matthew Salzberg
Source :
The New England journal of medicine. 384(9)
Publication Year :
2021

Abstract

Background Antibiotic therapy has been proposed as an alternative to surgery for the treatment of appendicitis. Methods We conducted a pragmatic, nonblinded, noninferiority, randomized trial comparing antibiotic therapy (10-day course) with appendectomy in patients with appendicitis at 25 U.S. centers. The primary outcome was 30-day health status, as assessed with the European Quality of Life-5 Dimensions (EQ-5D) questionnaire (scores range from 0 to 1, with higher scores indicating better health status; noninferiority margin, 0.05 points). Secondary outcomes included appendectomy in the antibiotics group and complications through 90 days; analyses were prespecified in subgroups defined according to the presence or absence of an appendicolith. Results In total, 1552 adults (414 with an appendicolith) underwent randomization; 776 were assigned to receive antibiotics (47% of whom were not hospitalized for the index treatment) and 776 to undergo appendectomy (96% of whom underwent a laparoscopic procedure). Antibiotics were noninferior to appendectomy on the basis of 30-day EQ-5D scores (mean difference, 0.01 points; 95% confidence interval [CI], -0.001 to 0.03). In the antibiotics group, 29% had undergone appendectomy by 90 days, including 41% of those with an appendicolith and 25% of those without an appendicolith. Complications were more common in the antibiotics group than in the appendectomy group (8.1 vs. 3.5 per 100 participants; rate ratio, 2.28; 95% CI, 1.30 to 3.98); the higher rate in the antibiotics group could be attributed to those with an appendicolith (20.2 vs. 3.6 per 100 participants; rate ratio, 5.69; 95% CI, 2.11 to 15.38) and not to those without an appendicolith (3.7 vs. 3.5 per 100 participants; rate ratio, 1.05; 95% CI, 0.45 to 2.43). The rate of serious adverse events was 4.0 per 100 participants in the antibiotics group and 3.0 per 100 participants in the appendectomy group (rate ratio, 1.29; 95% CI, 0.67 to 2.50). Conclusions For the treatment of appendicitis, antibiotics were noninferior to appendectomy on the basis of results of a standard health-status measure. In the antibiotics group, nearly 3 in 10 participants had undergone appendectomy by 90 days. Participants with an appendicolith were at a higher risk for appendectomy and for complications than those without an appendicolith. (Funded by the Patient-Centered Outcomes Research Institute; CODA ClinicalTrials.gov number, NCT02800785.).

Details

ISSN :
15334406
Volume :
384
Issue :
9
Database :
OpenAIRE
Journal :
The New England journal of medicine
Accession number :
edsair.doi.dedup.....4c7cf080bfbeb7afc50f26bdaa107ade